Social Security Survivor Benefits Equity Act
Summary
HR6424 is an early-stage bill that increases the Social Security lump sum death payment from $255 to $2,900 and indexes it to inflation. It has zero impact on publicly traded companies or financial markets because it only alters a benefit paid from general Treasury funds, with no corporate procurement, tax credit, or regulatory mechanism involved. The bill is referred to committee with no further action since December 2025.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR6424 has zero financial market impact — it changes a Social Security benefit paid from Treasury funds, not corporate revenue.
- 2.The bill is stalled at the earliest committee referral stage with no further action since December 2025, indicating very low passage probability.
- 3.No publicly traded companies are affected by this legislation; retail investors should ignore this bill for market decisions.
Market Implications
This bill has no implications for any financial market or publicly traded security. Retail investors should not factor HR6424 into any portfolio decision. The affected parties are individual Social Security survivors, not corporations, and the funding mechanism (Treasury general funds) bypasses all private sector channels.
Full Analysis
HR6424, the Social Security Survivor Benefits Equity Act, was introduced on December 4, 2025, by Rep. Gabe Amo (D-RI) with five cosponsors. The bill amends Section 202(i) of the Social Security Act to increase the lump sum death payment from $255 to $2,900 and index future payments to inflation (CPI-W). It was referred to the House Committee on Ways and Means, where it remains without any hearings, markups, or additional actions. A companion bill, S3357, exists in the Senate but also sits idle in the Finance Committee. The legislative velocity is near zero, and the bill is in the earliest possible stage with no real momentum. The money trail is nonexistent for markets: the benefit is paid from general Treasury funds through the Social Security trust fund, not through any corporate procurement or tax mechanism. No public company receives revenue, incurs costs, or faces regulatory change as a result of this bill. The affected parties are individual Social Security beneficiaries, not corporations. Because the bill involves no contracts, no tax credits, no regulatory standards, and no corporate mandates, there are no tickers to list and no sectors to analyze. The competitive landscape is entirely unaffected. The timeline is indeterminate; early-stage social welfare bills with junior sponsors and no committee action have an extremely low probability of passage in the current Congress.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Social Security Survivor Benefits Equity Act
Social Security Fairness Act of 2023
Social Security Caregiver Credit Act of 2026
Protecting Our Widows and Widowers in Retirement Act
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →